Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Large Biopsy 3

The Large Biopsy 3 test analyzes tissue samples to help diagnose various genetic conditions through histopathology. This test is essential for understanding cellular-level changes and guiding treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Tissue sample preserved in 10% neutral buffered formalin.
Results
Results are typically available within 6 days. Confirm with the laboratory before booking.
Preparation
Confirm specific preparation instructions with your doctor or the laboratory before the procedure.
Test priceKSh 12,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Large Biopsy 3 test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained persistent pain or swelling
  • ✓Family history of genetic conditions
  • ✓Pre-surgical evaluation
  • ✓Assessment of risk factors for genetic diseases
  • ✓Investigation of tissue abnormalities
02

In plain language

What this test helps you understand

This test aids in the diagnosis of various genetic conditions by examining tissue samples at a cellular level, providing crucial information for treatment planning.
The Large Biopsy 3 test is a diagnostic tool used to examine tissue samples for signs of genetic conditions. Performed by qualified general surgeons, this test helps identify abnormalities at a cellular level, which is crucial for accurate diagnosis and timely treatment planning. Understanding the results can help patients and their doctors make informed healthcare decisions.

This test involves the analysis of tissue samples preserved in 10% neutral buffered formalin. This preservation method ensures the tissue's integrity for detailed histopathological examination.

Individuals who might benefit from this test include those with unexplained symptoms like persistent pain or swelling, individuals with a family history of genetic conditions, patients preparing for surgery, or those with known risk factors for certain genetic diseases. A doctor's prescription is generally required, unless the test is for surgery, pregnancy, or travel abroad.

The Large Biopsy 3 test provides several benefits, including accurate diagnosis, informed treatment planning, and a better understanding of potential health risks. Results are typically available within 6 days and should be discussed with a healthcare provider for proper interpretation.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm specific preparation instructions with your doctor or the laboratory before the procedure.
SampleTissue sample preserved in 10% neutral buffered formalin.
MethodologyHistopathological examination of tissue samples.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
The accuracy of the test depends on the quality and representativeness of the tissue sample provided. Results should be interpreted in conjunction with clinical findings and other diagnostic tests.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

A biopsy is a medical procedure where a small sample of tissue is removed from the body for examination under a microscope.
Formalin is used to preserve the tissue sample, preventing degradation and ensuring accurate analysis during histopathological examination.
Yes, a doctor's prescription is generally required for this test, except in specific circumstances like surgery, pregnancy, or travel abroad.
Results are provided in a detailed report. It is important to discuss these findings with your healthcare provider for a complete understanding.
The biopsy procedure itself may cause some discomfort, but pain management options are available. Discuss any concerns with your doctor.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp